Share Price and Basic Stock Data
Last Updated: June 26, 2025, 11:17 am
PEG Ratio | -15.11 |
---|
Competitors of Rites Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
Fine Line Circuits Ltd | 38.4 Cr. | 79.8 | 115/78.6 | 192 | 18.4 | 0.00 % | 3.97 % | 2.30 % | 10.0 |
Filtra Consultants & Engineers Ltd | 63.6 Cr. | 58.0 | 116/53.0 | 21.8 | 22.0 | 3.88 % | 17.6 % | 12.2 % | 10.0 |
DRA Consultants Ltd | 25.8 Cr. | 23.5 | 69.0/21.8 | 9.60 | 29.9 | 0.00 % | 12.3 % | 8.55 % | 10.0 |
Zodiac Energy Ltd | 724 Cr. | 480 | 819/318 | 36.2 | 64.0 | 0.00 % | 20.2 % | 27.7 % | 10.0 |
Rites Ltd | 13,394 Cr. | 279 | 398/192 | 34.8 | 54.9 | 4.15 % | 20.8 % | 14.7 % | 10.0 |
Industry Average | 3,756.00 Cr | 501.64 | 58.98 | 119.08 | 0.77% | 12.13% | 10.85% | 10.00 |
Quarterly Result
Metric | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 766 | 605 | 659 | 677 | 687 | 544 | 582 | 683 | 643 | 486 | 541 | 576 | 615 |
Expenses | 562 | 426 | 478 | 484 | 496 | 383 | 445 | 514 | 467 | 380 | 435 | 458 | 430 |
Operating Profit | 204 | 179 | 181 | 193 | 191 | 161 | 138 | 169 | 176 | 106 | 106 | 117 | 186 |
OPM % | 27% | 30% | 27% | 29% | 28% | 30% | 24% | 25% | 27% | 22% | 20% | 20% | 30% |
Other Income | 23 | 32 | 25 | 27 | 19 | 18 | 28 | 19 | 27 | 25 | 22 | 44 | 27 |
Interest | 2 | 1 | 1 | 2 | 2 | 1 | 1 | 2 | 0 | 1 | 2 | 1 | 1 |
Depreciation | 24 | 15 | 17 | 19 | 17 | 16 | 14 | 15 | 16 | 14 | 15 | 16 | 17 |
Profit before tax | 201 | 195 | 188 | 199 | 191 | 163 | 150 | 171 | 187 | 115 | 111 | 144 | 195 |
Tax % | 29% | 26% | 26% | 26% | 27% | 26% | 27% | 25% | 27% | 21% | 26% | 24% | 27% |
Net Profit | 142 | 145 | 140 | 147 | 139 | 120 | 110 | 129 | 137 | 90 | 82 | 109 | 141 |
EPS in Rs | 2.85 | 2.86 | 2.76 | 2.91 | 2.75 | 2.25 | 2.10 | 2.50 | 2.62 | 1.64 | 1.52 | 2.08 | 2.76 |
Last Updated: May 31, 2025, 7:57 am
Below is a detailed analysis of the quarterly data for Rites Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 615.00 Cr.. The value appears strong and on an upward trend. It has increased from 576.00 Cr. (Dec 2024) to 615.00 Cr., marking an increase of 39.00 Cr..
- For Expenses, as of Mar 2025, the value is 430.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 458.00 Cr. (Dec 2024) to 430.00 Cr., marking a decrease of 28.00 Cr..
- For Operating Profit, as of Mar 2025, the value is 186.00 Cr.. The value appears strong and on an upward trend. It has increased from 117.00 Cr. (Dec 2024) to 186.00 Cr., marking an increase of 69.00 Cr..
- For OPM %, as of Mar 2025, the value is 30.00%. The value appears strong and on an upward trend. It has increased from 20.00% (Dec 2024) to 30.00%, marking an increase of 10.00%.
- For Other Income, as of Mar 2025, the value is 27.00 Cr.. The value appears to be declining and may need further review. It has decreased from 44.00 Cr. (Dec 2024) to 27.00 Cr., marking a decrease of 17.00 Cr..
- For Interest, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 1.00 Cr..
- For Depreciation, as of Mar 2025, the value is 17.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 16.00 Cr. (Dec 2024) to 17.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Mar 2025, the value is 195.00 Cr.. The value appears strong and on an upward trend. It has increased from 144.00 Cr. (Dec 2024) to 195.00 Cr., marking an increase of 51.00 Cr..
- For Tax %, as of Mar 2025, the value is 27.00%. The value appears to be increasing, which may not be favorable. It has increased from 24.00% (Dec 2024) to 27.00%, marking an increase of 3.00%.
- For Net Profit, as of Mar 2025, the value is 141.00 Cr.. The value appears strong and on an upward trend. It has increased from 109.00 Cr. (Dec 2024) to 141.00 Cr., marking an increase of 32.00 Cr..
- For EPS in Rs, as of Mar 2025, the value is 2.76. The value appears strong and on an upward trend. It has increased from 2.08 (Dec 2024) to 2.76, marking an increase of 0.68.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: May 15, 2025, 5:26 am
Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 1,096 | 1,013 | 1,218 | 1,351 | 1,497 | 2,047 | 2,474 | 1,905 | 2,662 | 2,628 | 2,453 | 2,218 |
Expenses | 816 | 664 | 871 | 1,005 | 1,071 | 1,469 | 1,811 | 1,353 | 1,933 | 1,869 | 1,792 | 1,703 |
Operating Profit | 280 | 348 | 347 | 347 | 427 | 578 | 663 | 552 | 729 | 759 | 661 | 515 |
OPM % | 26% | 34% | 29% | 26% | 28% | 28% | 27% | 29% | 27% | 29% | 27% | 23% |
Other Income | 127 | 147 | 208 | 210 | 154 | 200 | 268 | 101 | 84 | 103 | 92 | 118 |
Interest | 2 | 2 | 1 | 14 | 25 | 10 | 10 | 9 | 13 | 21 | 21 | 6 |
Depreciation | 20 | 26 | 37 | 38 | 36 | 38 | 47 | 52 | 66 | 67 | 61 | 62 |
Profit before tax | 385 | 468 | 518 | 505 | 519 | 730 | 874 | 593 | 735 | 774 | 670 | 565 |
Tax % | 32% | 33% | 34% | 33% | 31% | 33% | 28% | 25% | 27% | 26% | 26% | 25% |
Net Profit | 261 | 312 | 340 | 337 | 357 | 490 | 633 | 444 | 539 | 571 | 495 | 424 |
EPS in Rs | 10.42 | 12.49 | 13.55 | 6.57 | 6.85 | 9.39 | 12.32 | 9.00 | 10.74 | 11.28 | 9.48 | 8.01 |
Dividend Payout % | 20% | 20% | 40% | 46% | 32% | 54% | 65% | 72% | 79% | 91% | 95% | 110% |
YoY Net Profit Growth
Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
---|---|---|---|---|---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | 19.54% | 8.97% | -0.88% | 5.93% | 37.25% | 29.18% | -29.86% | 21.40% | 5.94% | -13.31% | -14.34% |
Change in YoY Net Profit Growth (%) | 0.00% | -10.57% | -9.86% | 6.82% | 31.32% | -8.07% | -59.04% | 51.25% | -15.46% | -19.25% | -1.03% |
Rites Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | 8% |
5 Years: | -2% |
3 Years: | -6% |
TTM: | -10% |
Compounded Profit Growth | |
---|---|
10 Years: | 2% |
5 Years: | -9% |
3 Years: | -9% |
TTM: | -15% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 19% |
3 Years: | 35% |
1 Year: | -19% |
Return on Equity | |
---|---|
10 Years: | 19% |
5 Years: | 18% |
3 Years: | 18% |
Last Year: | 15% |
Last Updated: Unknown
Balance Sheet
Last Updated: June 16, 2025, 11:27 am
Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 100 | 100 | 100 | 200 | 200 | 200 | 250 | 240 | 240 | 240 | 240 | 481 |
Reserves | 1,325 | 1,576 | 1,707 | 1,838 | 2,014 | 2,222 | 2,383 | 2,152 | 2,248 | 2,363 | 2,369 | 2,160 |
Borrowings | 0 | 0 | 173 | 83 | 55 | 48 | 47 | 37 | 28 | 5 | 8 | 9 |
Other Liabilities | 2,211 | 1,929 | 2,531 | 2,678 | 2,901 | 2,956 | 3,262 | 3,408 | 3,326 | 3,381 | 3,047 | 3,470 |
Total Liabilities | 3,636 | 3,605 | 4,511 | 4,799 | 5,170 | 5,426 | 5,943 | 5,837 | 5,842 | 5,991 | 5,664 | 6,119 |
Fixed Assets | 198 | 212 | 476 | 406 | 402 | 478 | 590 | 584 | 560 | 552 | 535 | 885 |
CWIP | 20 | 26 | 34 | 5 | 2 | 4 | 4 | 15 | 58 | 101 | 174 | 48 |
Investments | 228 | 226 | 220 | 328 | 133 | 141 | 261 | 289 | 205 | 130 | 109 | 117 |
Other Assets | 3,190 | 3,141 | 3,781 | 4,060 | 4,633 | 4,803 | 5,088 | 4,948 | 5,020 | 5,208 | 4,846 | 5,070 |
Total Assets | 3,636 | 3,605 | 4,511 | 4,799 | 5,170 | 5,426 | 5,943 | 5,837 | 5,842 | 5,991 | 5,664 | 6,119 |
Below is a detailed analysis of the balance sheet data for Rites Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 481.00 Cr.. The value appears strong and on an upward trend. It has increased from 240.00 Cr. (Mar 2024) to 481.00 Cr., marking an increase of 241.00 Cr..
- For Reserves, as of Mar 2025, the value is 2,160.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,369.00 Cr. (Mar 2024) to 2,160.00 Cr., marking a decrease of 209.00 Cr..
- For Borrowings, as of Mar 2025, the value is 9.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 8.00 Cr. (Mar 2024) to 9.00 Cr., marking an increase of 1.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 3,470.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,047.00 Cr. (Mar 2024) to 3,470.00 Cr., marking an increase of 423.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 6,119.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5,664.00 Cr. (Mar 2024) to 6,119.00 Cr., marking an increase of 455.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 885.00 Cr.. The value appears strong and on an upward trend. It has increased from 535.00 Cr. (Mar 2024) to 885.00 Cr., marking an increase of 350.00 Cr..
- For CWIP, as of Mar 2025, the value is 48.00 Cr.. The value appears to be declining and may need further review. It has decreased from 174.00 Cr. (Mar 2024) to 48.00 Cr., marking a decrease of 126.00 Cr..
- For Investments, as of Mar 2025, the value is 117.00 Cr.. The value appears strong and on an upward trend. It has increased from 109.00 Cr. (Mar 2024) to 117.00 Cr., marking an increase of 8.00 Cr..
- For Other Assets, as of Mar 2025, the value is 5,070.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,846.00 Cr. (Mar 2024) to 5,070.00 Cr., marking an increase of 224.00 Cr..
- For Total Assets, as of Mar 2025, the value is 6,119.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,664.00 Cr. (Mar 2024) to 6,119.00 Cr., marking an increase of 455.00 Cr..
Notably, the Reserves (2,160.00 Cr.) exceed the Borrowings (9.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
Month | Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | 280.00 | 348.00 | 174.00 | 264.00 | 372.00 | 530.00 | 616.00 | 515.00 | 701.00 | 754.00 | 653.00 | 506.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 108 | 137 | 161 | 125 | 114 | 109 | 124 | 112 | 101 | 126 | 134 |
Inventory Days | 27 | 32 | 22 | 302 | 20 | 81 | 96 | ||||
Days Payable | 165 | 408 | 184 | 572 | 144 | 105 | 589 | ||||
Cash Conversion Cycle | -30 | -239 | 161 | 125 | -47 | -161 | 1 | 112 | 77 | -367 | 134 |
Working Capital Days | -508 | -438 | -420 | -449 | -454 | -297 | -236 | -333 | -233 | -219 | -203 |
ROCE % | 30% | 28% | 21% | 24% | 30% | 33% | 23% | 29% | 30% | 25% |
Mutual Fund Holdings
Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
---|---|---|---|---|---|---|
HDFC Balanced Advantage Fund - Regular Plan | 800,000 | 0.05 | 37.6 | 800,000 | 2025-04-22 17:25:21 | 0% |
SBI PSU Fund | 695,000 | 3.53 | 32.67 | 695,000 | 2025-04-22 17:25:21 | 0% |
Aditya Birla Sun Life PSU Equity Fund | 470,821 | 1.49 | 22.13 | 470,821 | 2025-04-22 17:25:21 | 0% |
Axis Value Fund | 93,380 | 1.14 | 4.39 | 93,380 | 2025-04-22 17:25:21 | 0% |
Motilal Oswal Nifty Smallcap 250 Index Fund | 26,131 | 0.24 | 1.23 | 26,131 | 2025-04-22 17:25:21 | 0% |
SBI Nifty Smallcap 250 Index Fund | 20,411 | 0.24 | 0.96 | 20,411 | 2025-04-22 17:25:21 | 0% |
Axis Retirement Savings Fund - Dynamic Plan | 17,985 | 0.28 | 0.85 | 17,985 | 2025-04-22 17:25:21 | 0% |
ICICI Prudential Nifty Smallcap 250 Index Fund | 10,776 | 0.24 | 0.51 | 10,776 | 2025-04-22 17:25:21 | 0% |
HDFC NIFTY Smallcap 250 ETF | 5,514 | 0.24 | 0.26 | 5,514 | 2025-04-22 17:25:21 | 0% |
HDFC Nifty Smallcap 250 Index Fund | 4,517 | 0.24 | 0.21 | 4,517 | 2025-04-22 17:25:21 | 0% |
Key Financial Ratios
Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
---|---|---|---|---|---|
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Basic EPS (Rs.) | 8.01 | 18.95 | 23.76 | 21.49 | 17.54 |
Diluted EPS (Rs.) | 8.01 | 18.95 | 23.76 | 21.49 | 17.54 |
Cash EPS (Rs.) | 9.85 | 22.90 | 26.50 | 25.11 | 20.60 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 54.93 | 113.23 | 113.16 | 107.97 | 103.21 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 54.93 | 113.23 | 113.16 | 107.97 | 103.21 |
Revenue From Operations / Share (Rs.) | 46.15 | 102.07 | 109.37 | 110.77 | 77.38 |
PBDIT / Share (Rs.) | 12.91 | 30.39 | 35.23 | 33.59 | 27.02 |
PBIT / Share (Rs.) | 11.62 | 27.86 | 32.46 | 30.86 | 24.86 |
PBT / Share (Rs.) | 11.50 | 27.67 | 32.17 | 30.56 | 24.61 |
Net Profit / Share (Rs.) | 8.56 | 20.38 | 23.72 | 22.38 | 18.44 |
NP After MI And SOA / Share (Rs.) | 8.81 | 18.95 | 22.56 | 21.49 | 17.99 |
PBDIT Margin (%) | 27.98 | 29.77 | 32.21 | 30.32 | 34.92 |
PBIT Margin (%) | 25.18 | 27.29 | 29.67 | 27.86 | 32.13 |
PBT Margin (%) | 24.92 | 27.10 | 29.40 | 27.58 | 31.80 |
Net Profit Margin (%) | 18.55 | 19.96 | 21.68 | 20.20 | 23.83 |
NP After MI And SOA Margin (%) | 19.10 | 18.56 | 20.62 | 19.39 | 23.25 |
Return on Networth / Equity (%) | 16.04 | 17.45 | 20.81 | 20.74 | 18.07 |
Return on Capital Employeed (%) | 19.06 | 22.89 | 25.84 | 26.39 | 21.81 |
Return On Assets (%) | 6.92 | 8.04 | 9.07 | 8.86 | 7.41 |
Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
Total Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
Asset Turnover Ratio (%) | 0.37 | 0.42 | 0.43 | 0.45 | 0.31 |
Current Ratio (X) | 1.53 | 1.65 | 1.64 | 1.55 | 1.55 |
Quick Ratio (X) | 1.51 | 1.65 | 1.63 | 1.51 | 1.46 |
Dividend Payout Ratio (NP) (%) | 0.00 | 100.25 | 86.44 | 81.43 | 84.71 |
Dividend Payout Ratio (CP) (%) | 0.00 | 88.47 | 76.97 | 72.25 | 75.63 |
Earning Retention Ratio (%) | 0.00 | -0.25 | 13.56 | 18.57 | 15.29 |
Cash Earning Retention Ratio (%) | 0.00 | 11.53 | 23.03 | 27.75 | 24.37 |
Interest Coverage Ratio (X) | 107.02 | 155.04 | 120.27 | 111.34 | 108.05 |
Interest Coverage Ratio (Post Tax) (X) | 71.94 | 104.98 | 81.97 | 75.19 | 74.73 |
Enterprise Value (Cr.) | 7473.00 | 12933.72 | 5189.07 | 3146.36 | 2532.47 |
EV / Net Operating Revenue (X) | 3.37 | 5.27 | 1.97 | 1.18 | 1.36 |
EV / EBITDA (X) | 12.04 | 17.71 | 6.13 | 3.90 | 3.90 |
MarketCap / Net Operating Revenue (X) | 4.84 | 6.51 | 3.24 | 2.37 | 3.11 |
Retention Ratios (%) | 0.00 | -0.25 | 13.55 | 18.56 | 15.28 |
Price / BV (X) | 4.07 | 6.12 | 3.27 | 2.54 | 2.42 |
Price / Net Operating Revenue (X) | 4.84 | 6.51 | 3.24 | 2.37 | 3.11 |
EarningsYield | 0.03 | 0.02 | 0.06 | 0.08 | 0.07 |
After reviewing the key financial ratios for Rites Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 8.01. This value is within the healthy range. It has decreased from 18.95 (Mar 24) to 8.01, marking a decrease of 10.94.
- For Diluted EPS (Rs.), as of Mar 25, the value is 8.01. This value is within the healthy range. It has decreased from 18.95 (Mar 24) to 8.01, marking a decrease of 10.94.
- For Cash EPS (Rs.), as of Mar 25, the value is 9.85. This value is within the healthy range. It has decreased from 22.90 (Mar 24) to 9.85, marking a decrease of 13.05.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 54.93. It has decreased from 113.23 (Mar 24) to 54.93, marking a decrease of 58.30.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 54.93. It has decreased from 113.23 (Mar 24) to 54.93, marking a decrease of 58.30.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 46.15. It has decreased from 102.07 (Mar 24) to 46.15, marking a decrease of 55.92.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 12.91. This value is within the healthy range. It has decreased from 30.39 (Mar 24) to 12.91, marking a decrease of 17.48.
- For PBIT / Share (Rs.), as of Mar 25, the value is 11.62. This value is within the healthy range. It has decreased from 27.86 (Mar 24) to 11.62, marking a decrease of 16.24.
- For PBT / Share (Rs.), as of Mar 25, the value is 11.50. This value is within the healthy range. It has decreased from 27.67 (Mar 24) to 11.50, marking a decrease of 16.17.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 8.56. This value is within the healthy range. It has decreased from 20.38 (Mar 24) to 8.56, marking a decrease of 11.82.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 8.81. This value is within the healthy range. It has decreased from 18.95 (Mar 24) to 8.81, marking a decrease of 10.14.
- For PBDIT Margin (%), as of Mar 25, the value is 27.98. This value is within the healthy range. It has decreased from 29.77 (Mar 24) to 27.98, marking a decrease of 1.79.
- For PBIT Margin (%), as of Mar 25, the value is 25.18. This value exceeds the healthy maximum of 20. It has decreased from 27.29 (Mar 24) to 25.18, marking a decrease of 2.11.
- For PBT Margin (%), as of Mar 25, the value is 24.92. This value is within the healthy range. It has decreased from 27.10 (Mar 24) to 24.92, marking a decrease of 2.18.
- For Net Profit Margin (%), as of Mar 25, the value is 18.55. This value exceeds the healthy maximum of 10. It has decreased from 19.96 (Mar 24) to 18.55, marking a decrease of 1.41.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 19.10. This value is within the healthy range. It has increased from 18.56 (Mar 24) to 19.10, marking an increase of 0.54.
- For Return on Networth / Equity (%), as of Mar 25, the value is 16.04. This value is within the healthy range. It has decreased from 17.45 (Mar 24) to 16.04, marking a decrease of 1.41.
- For Return on Capital Employeed (%), as of Mar 25, the value is 19.06. This value is within the healthy range. It has decreased from 22.89 (Mar 24) to 19.06, marking a decrease of 3.83.
- For Return On Assets (%), as of Mar 25, the value is 6.92. This value is within the healthy range. It has decreased from 8.04 (Mar 24) to 6.92, marking a decrease of 1.12.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.37. It has decreased from 0.42 (Mar 24) to 0.37, marking a decrease of 0.05.
- For Current Ratio (X), as of Mar 25, the value is 1.53. This value is within the healthy range. It has decreased from 1.65 (Mar 24) to 1.53, marking a decrease of 0.12.
- For Quick Ratio (X), as of Mar 25, the value is 1.51. This value is within the healthy range. It has decreased from 1.65 (Mar 24) to 1.51, marking a decrease of 0.14.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 100.25 (Mar 24) to 0.00, marking a decrease of 100.25.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 88.47 (Mar 24) to 0.00, marking a decrease of 88.47.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has increased from -0.25 (Mar 24) to 0.00, marking an increase of 0.25.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 11.53 (Mar 24) to 0.00, marking a decrease of 11.53.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 107.02. This value is within the healthy range. It has decreased from 155.04 (Mar 24) to 107.02, marking a decrease of 48.02.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 71.94. This value is within the healthy range. It has decreased from 104.98 (Mar 24) to 71.94, marking a decrease of 33.04.
- For Enterprise Value (Cr.), as of Mar 25, the value is 7,473.00. It has decreased from 12,933.72 (Mar 24) to 7,473.00, marking a decrease of 5,460.72.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.37. This value exceeds the healthy maximum of 3. It has decreased from 5.27 (Mar 24) to 3.37, marking a decrease of 1.90.
- For EV / EBITDA (X), as of Mar 25, the value is 12.04. This value is within the healthy range. It has decreased from 17.71 (Mar 24) to 12.04, marking a decrease of 5.67.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.84. This value exceeds the healthy maximum of 3. It has decreased from 6.51 (Mar 24) to 4.84, marking a decrease of 1.67.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has increased from -0.25 (Mar 24) to 0.00, marking an increase of 0.25.
- For Price / BV (X), as of Mar 25, the value is 4.07. This value exceeds the healthy maximum of 3. It has decreased from 6.12 (Mar 24) to 4.07, marking a decrease of 2.05.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.84. This value exceeds the healthy maximum of 3. It has decreased from 6.51 (Mar 24) to 4.84, marking a decrease of 1.67.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.03, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Strength | Weakness |
---|---|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Rites Ltd:
- Net Profit Margin: 18.55%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 19.06% (Industry Average ROCE: 12.13%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 16.04% (Industry Average ROE: 10.85%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 71.94
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.51
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 34.8 (Industry average Stock P/E: 58.98)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 18.55%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Project Consultancy/Turnkey | Scope Minar, Delhi Delhi 110092 | cs@rites.com https://www.rites.com |
Management | |
---|---|
Name | Position Held |
Mr. Rahul Mithal | Chairman & M.D & CEO |
Mr. Krishna Gopal Agarwal | Director - Finance & CFO |
Mr. Arun Kumar Singh | Director - Projects |
Dr. Deepak Tripathi | Director - Technical |
Mr. Laxman Tammanna Tapashi | Independent Director |
Dr. Dineshananda Goswam | Independent Director |
Mr. Likha Togu | Independent Director |
Dr. Godawari Mishra | Independent Director |
Mr. Sandeep Jain | Government Nominee Director |
Mr. Shailendra Singh | Government Nominee Director |
FAQ
What is the intrinsic value of Rites Ltd?
Rites Ltd's intrinsic value (as of 26 June 2025) is ₹234.00 — 16.13% lower the current market price of 279.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 13,394 Cr. market cap, FY2025-2026 high/low of ₹398/192, reserves of 2,160 Cr, and liabilities of 6,119 Cr.
What is the Market Cap of Rites Ltd?
The Market Cap of Rites Ltd is 13,394 Cr..
What is the current Stock Price of Rites Ltd as on 26 June 2025?
The current stock price of Rites Ltd as on 26 June 2025 is 279.
What is the High / Low of Rites Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Rites Ltd stocks is ₹398/192.
What is the Stock P/E of Rites Ltd?
The Stock P/E of Rites Ltd is 34.8.
What is the Book Value of Rites Ltd?
The Book Value of Rites Ltd is 54.9.
What is the Dividend Yield of Rites Ltd?
The Dividend Yield of Rites Ltd is 4.15 %.
What is the ROCE of Rites Ltd?
The ROCE of Rites Ltd is 20.8 %.
What is the ROE of Rites Ltd?
The ROE of Rites Ltd is 14.7 %.
What is the Face Value of Rites Ltd?
The Face Value of Rites Ltd is 10.0.